Who owns NEUROCRINE BIOSCIENCES INC (NBIX)? Elite investor 13F holders
7 tracked elite investors reported holding NEUROCRINE BIOSCIENCES INC as of 2026-06-30, including Dodge & Cox Funds, Renaissance Technologies LLC, Gotham Asset Management, Bridgewater Associates, Sarissa Capital. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
7 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Dodge & Cox Funds | NEUROCRINE BIOSCIENCES INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 941218594.00 USD | 5584707.000000 | Shares | add | Original filing |
| Renaissance Technologies LLC | NEUROCRINE BIOSCIENCES INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 393680402.00 USD | 2335897.000000 | Shares | reduce | Original filing |
| Gotham Asset Management | NEUROCRINE BIOSCIENCES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 62622213.00 USD | 371568.000000 | Shares | add | Original filing |
| Bridgewater Associates | NEUROCRINE BIOSCIENCES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 34663773.00 USD | 205677.000000 | Shares | add | Original filing |
| Sarissa Capital | NEUROCRINE BIOSCIENCES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 19639889.00 USD | 116533.000000 | Shares | hold | Original filing |
| GMO | NEUROCRINE BIOSCIENCES INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 12206990.00 USD | 72430.000000 | Shares | add | Original filing |
| D.E. Shaw | NEUROCRINE BIOSCIENCES INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 943627.00 USD | 5599.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.